Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 93, Issue 10, 1999, Pages 715-718

  Senderovitz, T ^a   Vestbo, J ^b   Frandsen, J ^c   Maltbaek N ^d   Norgaard M ^e   Nielsen, C ^f   Kampmann, J P ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e Anæstesiologisk Center   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INSOMNIA; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SIDE EFFECT; SPIROMETRY;

EID: 0032712477     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90038-0     Document Type: Article

References (19)

1. Anonymous. International consenses report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institute of Heath. Bethesda, Maryland 20892. Publication no. 92-3091. Eur Respir J 1992; 5: 601-641.
2. Lenfant C, ed. Global strategy for asthma management and prevention. NHBLI/WHO workshop report. NIH publication 1995, no. 95-3659.
3. Niewoehner DE, Erbland ML. Systemic corticosteroids in COPD. An unresolved clinical dilemma. Chest 1996; 110: 867-869.
4. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8: 1398-1420.
5. Mendella LA, Manfreda J, Warren CP, Anthonisen NR. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med 1982; 96: 14-21.
6. Wiggins J, Feher MD, Lant AF, Collins JV. Steroid trials in the assessment of reversibility of air flow limitation: a survey of current clinicial practice of chest physicians. Respir Med 1991; 85: 295-299.
7. Stoller JK, Gerbarg ZB, Feinstein AR. Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy. J Gen Intern Med 1987; 2: 29-35.
8. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 1991; 114: 216-223.
9. Weir DC, Burge PS. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 1993; 48: 309-316.
10. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised place-bo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group, Lancet 1998; 351: 773-780.
11. Bourbeau J, Rouleau MY, Boucher S. Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Thorax 1998; 53: 477-482.
12. Renkema TE, Schouten JP, Koeter GH, Postma DS. Effects of long-term treatment with corticosteroids in COPD.Chest 1996; 109: 1156-1162.
13. Pauwels RA, Lofdahl CG, Pride NB, Postma DS, Laitinen LA, Ohlsson SV. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J 1992; 5: 1254-1261.
14. Tweeddale PM, Alexander F, McHardy GJ. Short term variability in FEVj and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987; 42: 487-190.
15. Weir DC, Gove RI, Robertson AS, Burge PS. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990; 45: 112-117.
16. Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PM. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 1990; 45: 190-194.
17. Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic NonSpecific Lung Disease (CNSLD) Study Group. Thorax 1992; 47: 429-436.
18. Postma DS, Renkema TE, Koeter GH. Effects of corticosteroids in "chronic bronchitis" and "chronic obstructive airways disease". Agents Actions Suppl 1990; 30: 41-57.
19. Guyatt GH, Townsend M, Nogradi S, Pugsley SO, Keller JL, Newhouse MT. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med 1988; 148: 1949-1952.